HCPLive
64th American Academy of Neurology Annual Meeting

64th American Academy of Neurology Annual Meeting | AAN 2012

This year's meeting will focus on providing attendees top education, breakthrough science, and practice improvement by offering morning reports, clinical skills pavilions, self-assessment courses, Neuro Flashes, and didactic review and update courses.

Conference Coverages

Pregabalin More Efficient When Treating RLS
In the first long-term active-comparator trial of efficacy and augmentation in restless leg syndrome (RLS), outcomes with pregabalin were better than those observed with pramipexole.
24-Hour ICH Score Better Prognostic Indicator Than ICH Score at Admission
Although the intra-cerebral hemorrhage (ICH) score at hospital admission is typically used to estimate the potential prognosis in stroke patients, a new study suggests that the 24-hour ICH score is a more accurate assessment.
Pregabalin Safe and Effective for Relief of Chronic Neuopathic Pain and Related Sleep Disturbance
According to a randomized, controlled clinical trial reported at the Emerging Science session, pregabalin was found effective in relieving chronic neuropathic pain and pain-related sleep disturbances associated with spinal cord injury.
24-Month Study Confirms Efficacy of Oral Fingolimod in MS
Results from the FREEDOMS II trial found oral fingolimod administered at a daily dose of 0.5 mg to reduce relapse rates by almost 50% in patients with relapsing-remitting multiple sclerosis (RRMS).
Epigenetics Will Someday Transform the Science of Brain and Behavior
Mark F. Mehler, MD, discussed how brain and behavior are becoming better understood through the emerging discipline of epigenetics.
Levodopa-Carbidopa Intestinal Gel Prolongs Treatment Benefit In Parkinson's Disease
The 2012 Annual Meeting of the American Academy of Neurology presented a phase 3 randomized, double-blind clinical trial which found that levodopa-carbidopa intestinal gel was more effective than standard oral levodopa-carbidopa.
Oral Drug Reduces MRI Signs of Multiple Sclerosis
An investigational oral drug for multiple sclerosis (MS), called ONO-4641, reduced the number of lesions detected on magnetic resonance imaging (MRI) scans

Most Popular

$vacMongoViewPlus$ $vAR$